[Results of a study of a live intranasal influenza vaccine in the immunization of children 3 to 15 years old].
A total of 10,971 children aged 3-15 years were immunized with live influenza vaccine (the variant intended for children), type A (H1N1). The vaccine proved to be nonreactogenic and produced no harmful effect on the child organism. The genetic stability of the vaccine strain and its high immunogenic activity were shown.